Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | MLYCD | O95822 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21135694 | 0.87 | L3MBTL1 (0.38) | KMT2AMEN1L3MBTL1TDP1RORC | |
| SCHEMBL21135755 | 0.83 | KMT2A (0.33) | KMT2AMEN1L3MBTL1TDP1RORC | |
| SCHEMBL21135693 | 0.80 | ALDH1A1 (0.36) | KMT2ATDP1RORCALDH1A1HPGD | |
| SCHEMBL21136598 | 0.80 | MEN1 (0.34) | KMT2AMEN1L3MBTL1TDP1RORC | |
| SCHEMBL21135699 | 0.78 | SMN1; SMN2 (0.38) | KMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL12334751 | 0.76 | KMT2A (0.41) | KMT2AMEN1L3MBTL1TDP1ALDH1A1 | |
| SCHEMBL12452801 | 0.76 | ALDH1A1 (0.43) | KMT2AMEN1L3MBTL1ALDH1A1HPGD | |
| SCHEMBL15858326 | 0.74 | ALDH1A1 (0.34) | KMT2AMEN1ALDH1A1HPGDGAA | |
| SCHEMBL12334765 | 0.74 | L3MBTL1 (0.39) | KMT2AMEN1L3MBTL1TDP1ALDH1A1 | |
| SCHEMBL21135697 | 0.72 | ALDH1A1 (0.33) | KMT2AMEN1ALDH1A1HPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | RER1, ACTR5, RAD51 | KMT2A 3332/4885MEN1 2511/4885L3MBTL1 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.